The Anti-Cancer Properties of Cannabidiol and
Δ-9Tetrahydrocannabinol in Haematological
Malignancies In Vitro
Volume 5 - Issue 1
Cees Th Smit Sibinga*
- International Development of Transfusion Medicine, IQM Consulting and University of Groningen, The Netherlands
Received: October 28, 2021 Published: November 10, 2021
Corresponding author: Cees Th Smit Sibinga, Professor of International Development of Transfusion Medicine, IQM Consulting and
University of Groningen, The Netherlands
DOI: 10.32474/OAJOM.2021.05.000203
Fulltext
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Blood transfusion has been in the mind of people since ages
as a substance that carries all the blessings of life, despite the
serious events that happened during the époques where little
or no knowledge existed on the characteristics of blood and
its composition. The start of breakthroughs happened in the
19th Century, with a tremendous acceleration in the science of
transfusion medicine during the 20th Century, which resulted
in 23 Nobel laureates up till today [1]. With the socio-economic
developments life expectancy has been improved in a growing
number of populations spread over this globe [2]. With that we are
now able to initiate long term observative studies to understand
the slow developing effects of interventions leading to morbidities
that become noticeable after years and years. Blood transfusion,
be it whole blood or separated cellular components, when selected
and prepared with caution and professionalism, seems time after
time to generate blessings, supporting a lifesaving balance to occur
in otherwise seriously life-threatening situations. That has opened
numerous treatment doors for a manifold of disease entities all
over the world, including the wide range of malignancies.
Introduction|
Supportive Haemotherapy|
Impact of Haemotherapy on the Development of
Malignancies|
Impact of Haemotherapy on Recurrence and
Mortality in Colorectal Cancer patients|
Epilogue|
References|